Abstract
After synthesis and purification of an oligonucleotide, the final product usually contains a low level of n-1 congeneric species. We have sequenced the n-1 population of a 25mer phosphodiester oligonucleotide. The n-1 band was cut from the gel and eluted. Oligonucleotides were tailed with dA and annealed to a dT-tailed plasmid. The recombinant plasmid was ligated and used to transform competent bacteria. Our results show that the n-1 population was heterogeneous. The frequency of truncated nucleotides at the 3'-end was much higher than at the 5'-end of the oligomer. No truncated nucleotides were found in the last four nucleotides at the 5'-end. Our results also show that the chain of oligonucleotides can grow on unreacted sites of a controlled-pore glass support.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agrawal S. Antisense oligonucleotides as antiviral agents. Trends Biotechnol. 1992 May;10(5):152–158. doi: 10.1016/0167-7799(92)90203-8. [DOI] [PubMed] [Google Scholar]
- Agrawal S., Iyer R. P. Modified oligonucleotides as therapeutic and diagnostic agents. Curr Opin Biotechnol. 1995 Feb;6(1):12–19. doi: 10.1016/0958-1669(95)80003-4. [DOI] [PubMed] [Google Scholar]
- Bayever E., Iversen P. L., Bishop M. R., Sharp J. G., Tewary H. K., Arneson M. A., Pirruccello S. J., Ruddon R. W., Kessinger A., Zon G. Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial. Antisense Res Dev. 1993 Winter;3(4):383–390. doi: 10.1089/ard.1993.3.383. [DOI] [PubMed] [Google Scholar]
- Crooke S. T., Grillone L. R., Tendolkar A., Garrett A., Fratkin M. J., Leeds J., Barr W. H. A pharmacokinetic evaluation of 14C-labeled afovirsen sodium in patients with genital warts. Clin Pharmacol Ther. 1994 Dec;56(6 Pt 1):641–646. doi: 10.1038/clpt.1994.189. [DOI] [PubMed] [Google Scholar]
- Erlich H. A., Gelfand D., Sninsky J. J. Recent advances in the polymerase chain reaction. Science. 1991 Jun 21;252(5013):1643–1651. doi: 10.1126/science.2047872. [DOI] [PubMed] [Google Scholar]
- Habus I., Agrawal S. Improvement in the synthesis of oligonucleotides of extended length by modification of detritylation step. Nucleic Acids Res. 1994 Oct 11;22(20):4350–4351. doi: 10.1093/nar/22.20.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Letsinger R. L., Lunsford W. B. Synthesis of thymidine oligonucleotides by phosphite triester intermediates. J Am Chem Soc. 1976 Jun 9;98(12):3655–3661. doi: 10.1021/ja00428a045. [DOI] [PubMed] [Google Scholar]
- Okayama H., Berg P. High-efficiency cloning of full-length cDNA. Mol Cell Biol. 1982 Feb;2(2):161–170. doi: 10.1128/mcb.2.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pon R. T. Solid-phase supports for oligonucleotide synthesis. Methods Mol Biol. 1993;20:465–496. doi: 10.1385/0-89603-281-7:465. [DOI] [PubMed] [Google Scholar]
- Stein C. A., Cheng Y. C. Antisense oligonucleotides as therapeutic agents--is the bullet really magical? Science. 1993 Aug 20;261(5124):1004–1012. doi: 10.1126/science.8351515. [DOI] [PubMed] [Google Scholar]
- Temsamani J., Kubert M., Agrawal S. Sequencing of synthetic oligonucleotides and analogs by homopolymeric tailing. Nucleic Acids Res. 1995 Apr 11;23(7):1271–1272. doi: 10.1093/nar/23.7.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang R., Yan J., Shahinian H. K., Shahinian H., Amin G., Lu Z., Liu T., Saag M. S., Jiang Z., Temsamani J. Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects. Clin Pharmacol Ther. 1995 Jul;58(1):44–53. doi: 10.1016/0009-9236(95)90071-3. [DOI] [PubMed] [Google Scholar]